Stem Cell Transplant for Children with Sickle Cell Anemia: Parent and Patient Interest

Biology of Blood and Marrow Transplantation

Volumn 18, Issue 11, 2012, Pages 1709-1715

  Roth, Michael ^a   Krystal, Julie ^a   Manwani, Deepa ^a   Driscoll, Catherine ^a   Ricafort, Rosanna ^a  

^a CHILDREN S HOSPITAL AT MONTEFIORE   (United States)

Author keywords

Hematopoietic stem cell transplant; Prognosis; Quality of life; Sickle cell disease

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; DEMOGRAPHY; DISEASE SEVERITY; EXCHANGE BLOOD TRANSFUSION; FEMALE; HEALTH SURVEY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LIFESPAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE; RISK BENEFIT ANALYSIS; SICKLE CELL ANEMIA;

ADOLESCENT; ANEMIA, SICKLE CELL; BETA-THALASSEMIA; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LIFE EXPECTANCY; PARENTAL CONSENT; PARENTS; PATIENT ACCEPTANCE OF HEALTH CARE; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84867488154     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2012.05.013     Document Type: Article

References (37)

1. Hoppe C., Styles L., Vichinsky E. The natural history of sickle cell disease. Curr Opin Pediatr 1998, 10:49-52.
2. Powars D.R., Chan L.S., Hiti A., Ramicone E., Johnson C. Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine (Baltimore) 2005, 84:363-376.
3. Platt O.S., Brambilla D.J., Rosse W.F., et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994, 330:1639-1644.
4. Ballas S.K., Bauserman R.L., McCarthy W.F., Waclawiw M.A. The impact of hydroxyurea on career and employment of patients with sickle cell anemia. J Natl Med Assoc 2010, 102:993.
5. Panepinto J.A., O'Mahar K.M., DeBaun M.R., Loberiza F.R., Scott J.P. Health-related quality of life in children with sickle cell disease: child and parent perception. Br J Haematol 2005, 130:437-444.
6. Brandow A.M., Brousseau D.C., Pajewski N.M., Panepinto J.A. Vaso-occlusive painful events in sickle cell disease: impact on child well-being. Pediatr Blood Cancer 2010, 54:92-97.
7. Palermo T.M., Schwartz L., Drotar D., McGowan K. Parental report of health-related quality of life in children with sickle cell disease. J Behav Med 2002, 25:269-283.
8. Bernaudin F., Socie G., Kuentz M., et al. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood 2007, 110:2749-2756.
9. Steinberg M.H. Management of sickle cell disease. N Engl J Med 1999, 340:1021-1030.
10. Vermylen C., Cornu G., Ferster A., et al. Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium. Bone Marrow Transplant 1998, 22:1-6.
11. Walters M.C., Patience M., Leisenring W., et al. Bone marrow transplantation for sickle cell disease. N Engl J Med 1996, 335:369-376.
12. Walters M.C., Storb R., Patience M., et al. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood 2000, 95:1918-1924.
13. Kodish E., Lantos J., Stocking C., Singer P.A., Siegler M., Johnson F.L. Bone marrow transplantation for sickle cell disease. A study of parents' decisions. N Engl J Med 1991, 325:1349-1353.
14. van Besien K., Koshy M., Anderson-Shaw L., et al. Allogeneic stem cell transplantation for sickle cell disease. A study of patients' decisions. Bone Marrow Transplant 2001, 28:545-549.
15. Walters M.C., Patience M., Leisenring W., et al. Barriers to bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant 1996, 2:100-104.
16. Dampier C., LeBeau P., Rhee S., et al. Health-related quality of life in adults with sickle cell disease (SCD): a report from the comprehensive sickle cell centers clinical trial consortium. Am J Hematol 2011, 86:203-205.
17. Varni J.W., Seid M., Kurtin P.S. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care 2001, 39:800-812.
18. Varni J.W., Burwinkle T.M., Katz E.R., Meeske K., Dickinson P. The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module. Cancer 2002, 94:2090-2106.
19. Varni J.W., Burwinkle T.M., Rapoff M.A., Kamps J.L., Olson N. The PedsQL in pediatric asthma: reliability and validity of the Pediatric Quality of Life Inventory generic core scales and asthma module. J Behav Med 2004, 27:297-318.
20. Varni J.W., Burwinkle T.M., Seid M., Skarr D. The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr 2003, 3:329-341.
21. Panepinto J.A., Pajewski N.M., Foerster L.M., Hoffmann R.G. The performance of the PedsQL generic core scales in children with sickle cell disease. J Pediatr Hematol Oncol 2008, 30:666-673.
22. Varni JW. The PedsQL4.0 measurement model for the pediatric quality of life inventory version 4.0: administration guidelines 1999.
23. Panepinto J.A., Walters M.C., Carreras J., et al. Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research. Br J Haematol 2007, 137:479-485.
24. Walters M.C., Patience M., Leisenring W., et al. Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant 2001, 7:665-673.
25. Anie K.A. Psychological complications in sickle cell disease. Br J Haematol 2005, 129:723-729.
26. Hurtig A.L., White L.S. Psychosocial adjustment in children and adolescents with sickle cell disease. J Pediatr Psychol 1986, 11:411-427.
27. Gaston M.H., Verter J.I., Woods G., et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med 1986, 314:1593-1599.
28. Quinn C.T., Rogers Z.R., McCavit T.L., Buchanan G.R. Improved survival of children and adolescents with sickle cell disease. Blood 2010, 115:3447-3452.
29. Halasa N.B., Shankar S.M., Talbot T.R., et al. Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis 2007, 44:1428-1433.
30. Voskaridou E., Christoulas D., Bilalis A., et al. The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). Blood 2010, 115:2354-2363.
31. Wierenga K.J., Hambleton I.R., Lewis N.A. Survival estimates for patients with homozygous sickle-cell disease in Jamaica: a clinic-based population study. Lancet 2001, 357:680-683.
32. Secretariat U. World population prospects: the 2006 revision. PLACE: the Population Division of the Department of Economic and Social Affairs of the UN Secretariat. Available at: http://www.unorg/esa/population/publications/wpp2006/wpp2006htm.
33. McClish D.K., Penberthy L.T., Bovbjerg V.E., et al. Health related quality of life in sickle cell patients: the PiSCES project. Health Qual Life Outcomes 2005, 3:50.
34. Swanson M.E., Grosse S.D., Kulkarni R. Disability among individuals with sickle cell disease: literature review from a public health perspective. Am J Prev Med 2011, 41(6 Suppl 4):S390-S397.
35. Steinberg M.H. Predicting clinical severity in sickle cell anaemia. Br J Haematol 2005, 129:465-481.
36. Miller S.T., Sleeper L.A., Pegelow C.H., et al. Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med 2000, 342:83-89.
37. Quinn C.T., Lee N.J., Shull E.P., Ahmad N., Rogers Z.R., Buchanan G.R. Prediction of adverse outcomes in children with sickle cell anemia: a study of the Dallas Newborn Cohort. Blood 2008, 111:544-548.